Eloxx Pharmaceuticals, Inc. (ELOX)
NASDAQ: ELOX · Real-Time Price · USD
17.57
-0.14 (-0.79%)
Aug 7, 2026, 4:00 PM EDT - Market closed
Eloxx Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Eloxx Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $41.5. The average 1-year stock price forecast is 136.20% higher than the current stock price, while the lowest is $40 (+127.66%) and the highest is $43 (+144.74%).
Price Target: $41.5 (+136.20%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Eloxx Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '23 | Nov '23 | Feb '24 | Jul '26 |
|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 |
| Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| LifeSci Capital | LifeSci Capital | Buy Initiates $40 | Buy | Initiates | $40 | +127.66% | Jul 22, 2026 |
| Guggenheim | Guggenheim | Buy Initiates $43 | Buy | Initiates | $43 | +144.74% | Jul 20, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-88.44
EPS Next Year
148.72
from -88.44
EPS and Forward PE are based on non-GAAP adjusted numbers.